Drug platform to treat the millions of people suffering from inflammatory bowel disease and colorectal cancers.
Bio-Logic Hawaii is developing a proprietary drug platform to treat the millions of people suffering from inflammatory bowel disease and colorectal cancers.
Bio-Logic’s product is an orally administered anti-inflammatory drug treating Inflammatory Bowl Disease or IBD’s (two major types are Crohn’s disease and Ulcerative Colitis), for which there is currently no cure available. Available treatments provide short-term relief, long-term remission or reduced risks of complications. Current treatments include anti-inflammatory drugs and steroids, which are usually not taken long term; immune system suppressors, which target your immune system rather than directly treating inflammation and many times require injections; antibiotics, for which there is no strong evidence that they are effective for Crohn’s disease; and surgery. Bio-Logic will target just a specific region of inflammation (this implication is currently being evaluated), will be orally transmitted and taken on a daily basis to proactively ensure long-term remission of IBD.